| AAV | adeno-associated virus |
| ABC | antibody biopolymer conjugate |
| ADAM | a disintegrin and metalloprotease |
| AGEs | advanced glycation end products |
| aMMP-8 | active matrix metalloproteinase-8 |
| ANG2 | Angiopoietin 2 |
| α-SMA | α-smooth muscle actin |
| BCVA | best-corrected visual acuity |
| BM | basement membrane |
| BMDMs | bone marrow-derived macrophages |
| BRB | blood–retina barrier |
| CCR2 | C-C motif chemokine receptor 2 |
| CECs | choroidal endothelial cells |
| CNV | choroidal neovascularization |
| COST | cone outer segment termination |
| CTGF | connective tissue growth factor |
| CX3CL1 | C-X3-C motif chemokine ligand 1 |
| CX3CR1 | C-X3-C motif chemokine receptor 1 |
| CXCL8 | C-X-C motif chemokine ligand 8 |
| DAF | decay-accelerating factor |
| DME | diabetic macular edema |
| DMI | diabetic macular ischemia |
| DR | diabetic retinopathy |
| DRIL | disorganization of the retinal inner layers |
| ECM | extracellular matrix |
| ELM | external limiting membrane |
| EMT | epithelial-to-mesenchymal transition |
| EndMT | endothelial-to-mesenchymal transition |
| ERM | epiretinal membrane |
| EZ | ellipsoid zone |
| FAK | focal adhesion kinase |
| FBN2 | fibrillin-2 |
| FDA | Food and Drug Administration |
| FH | factor H |
| FI | factor I |
| FSP-1 | fibroblast-specific protein-1 |
| FVM | fibrovascular membranes |
| GA | geographic atrophy |
| GAG | glycosaminoglycans |
| GALNS | galactosamine-6 sulfatase |
| GPCR | G protein-coupled receptor |
| HIF-1α | hypoxia-inducible factor-1α |
| IL-1β | interleukin-1β |
| LAP | latency-associated peptide |
| LATS | large tumor suppressor kinases |
| MAC | membrane attack complex |
| MCP | membrane cofactor protein |
| MCP-1 | monocyte chemoattractant protein-1 |
| MLCs | myosin light chains |
| MLCK | myosin light chain kinase |
| MMT | macrophage-to-myofibroblast transition |
| MNV | macular neovascularization |
| MST | mammalian STE20-like kinases |
| NAD+ | nicotinamide adenine dinucleotide |
| nAMD | neovascular age-related macular degeneration |
| NF-κB | nuclear factor-κB |
| NICD | Notch intracellular domain |
| NLRP3 | the NLR family pyrin domain-containing 3 |
| NPDR | non-proliferative diabetic retinopathy |
| OCT | optical coherence tomography |
| OCTA | OCT-angiography |
| PBMCs | peripheral blood mononuclear cells |
| PDGF | platelet-derived growth factor |
| PDR | proliferative diabetic retinopathy |
| PDS | Port Delivery System |
| PMT | pericyte-to-myofibroblast transition |
| PPV | pars plana vitrectomy |
| RAGE | receptor for AGE |
| RGD | arginine–glycine–aspartate |
| ROCK | Rho-associated coiled-coil-containing protein kinase |
| ROS | reactive oxygen species |
| RPE | retinal pigment epithelium |
| S1P | sphingosine-1-phosphate |
| SHRM | subretinal hyperreflective material |
| SRF | subretinal fluid |
| T&E | treat-and-extend |
| TEAD | TEA domain family of DNA-binding proteins |
| TGF-β | transforming growth factor beta |
| TKI | tyrosine kinase inhibitor |
| TNF | tumor necrosis factor |
| TRD | tractional retinal detachment |
| VEGF-A | vascular endothelial growth factor A |
| ZEB | zinc finger E-box binding homeobox |
| ZO-1 | Zonula Occludens-1 |